Competitive Technologies: FDA-Approved Medical Device Hitting the Revenue Line - trackseekingalpha

Sign Up | Log In | What is SocialPicks?

Competitive Technologies: FDA-Approved Medical Device Hitting the Revenue Line
Nov 09, 2009 09:13 AM UTC

trackseekingalpha

Return	Risk
-11.17%	HIGH

Tracked Blogger

Profile & Performance

Subscribe to author

Symbol	Sentiment	Start	Return	Closed
CTT	n/a

Via Long Investment Ideas from Seeking Alpha:

Competitive Technologies (CTT) is begining to see revenues generated as a result of the FDA approval of its very promising chronic pain mangement medical device. The company has already announced orders for 70 units and will recognize revenue for 17 units shipped in the past quarter (ending Oct. 31).

Five insiders, including the CEO, took advantage of the permitted window for insider purchaes last week and added to their holdings, despite the stock's 80% appreciation YTD.

Read the rest of original post »

Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.